Overview
Swedish medical imaging IT firm's Q3 net sales rose 5.1% yr/yr
Q3 operating profit decreased yr/yr, with a 21.8% operating margin
Recurring revenue grew 20.2% yr/yr, with cloud recurring revenue up 53.3%
Outlook
Company expects delays in Secure Communications to impact financials until next year
Sectra is transitioning medical operations to service sales to boost profitability
Company invests in AI and cloud services to enhance offerings
Result Drivers
ORDER BOOKINGS - Contracted order bookings rose 35% to SEK 1,306.7 mln, driven by guaranteed orders
CLOUD REVENUE - Cloud recurring revenue increased 53.3% to SEK 249.5 mln, boosting overall recurring revenue
SERVICE SALES TRANSITION - Transition to service sales and new customer deployments contributed to sales growth
Company press release: ID:nWkr1dVBDc
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
Slight Miss*
SEK 892 mln
SEK 893 mln (2 Analysts)
Q3 EBIT
Beat
SEK 194.10 mln
SEK 154 mln (2 Analysts)
Q3 EBIT Margin
21.80%
Q3 Orders
SEK 1.31 bln
Q3 Recurring Revenue
SEK 632 mln
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Wall Street's median 12-month price target for Sectra AB is SEK240.00, about 29% above its March 5 closing price of SEK186.00
The stock recently traded at 55 times the next 12-month earnings vs. a P/E of 89 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)